Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zylo Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Zylo Therapeutics

Zylo Therapeutics

Zylö Therapeutics provides a novel Nanopod system for sustained-release drug delivery.

HQ
Greenville, SC, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Zylö Therapeutics, founded in Greenville, SC, is dedicated to revolutionizing drug delivery through its innovative Nanopod system. The company's core mission is to enhance the efficacy and safety of pharmaceuticals by providing a sustained-release delivery mechanism. Zylö's proprietary Z-pods® technology encapsulates drugs, allowing for controlled release and improved therapeutic outcomes. Their market focus includes pharmaceuticals, cosmeceuticals, and potentially other sectors requiring precise drug delivery solutions.

Notable figures affiliated with Zylö Therapeutics include experts in drug delivery and pharmaceutical development. The company has garnered attention from investors interested in cutting-edge medical technologies. Key achievements include successful partnerships and collaborations that have validated their technology's potential. Overall, Zylö Therapeutics is making a significant impact by addressing critical challenges in drug delivery, aiming to improve patient outcomes and advance the field of medicine.

Zylo Therapeutics - Similar Companies

Zenomics logo

Zenomics

Advanced NanoTherapies logo

Advanced NanoTherapies

Cytonus Therapeutics logo

Cytonus Therapeutics

cytonus.com

NMB Therapeutics logo

NMB Therapeutics

NanoMedical Systems logo

NanoMedical Systems

nanomedsys.com

ZWI Therapeutics logo

ZWI Therapeutics

zwitx.com

Lyndra logo

Lyndra

lyndra.com

Piezo Therapeutics logo

Piezo Therapeutics

piezotx.com

NanoPharmaceuticals logo

NanoPharmaceuticals

ProLynx logo

ProLynx

prolynxinc.com

Enable Therapeutics logo

Enable Therapeutics

Syntis Bio logo

Syntis Bio

syntis.bio

InSitu Biologics logo

InSitu Biologics

Anogen Life Sciences logo

Anogen Life Sciences

Ezra Innovations logo

Ezra Innovations

ezrapharma.com

Zylo Therapeutics - Quick Facts

Who are Zylo Therapeutics' competitors?

Companies similar to Zylo Therapeutics include Zenomics, Advanced NanoTherapies, Cytonus Therapeutics and NMB Therapeutics.

When was Zylo Therapeutics founded?

Zylo Therapeutics was founded in 2017.

Where is Zylo Therapeutics' headquarters located?

Zylo Therapeutics' headquarters is located in Greenville, SC, US.

When was Zylo Therapeutics' last funding round?

Zylo Therapeutics' most recent funding round was for $294k (USD) in May 2023.

How much has Zylo Therapeutics raised to-date?

As of May 31, 2023, Zylo Therapeutics has raised a total of $13.5M (USD).

How many employees does Zylo Therapeutics have?

Zylo Therapeutics has 32 employees as of Feb 5, 2024.

Zylo Therapeutics - Classification

Ownership
  • Private
Technology
  • Nanotechnology
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified